- Home
- TCRT vs TTNP Comparison
TCRT vs TTNP Comparison
Compare TCRT & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRT
- TTNP
- Stock Information
- Founded
- TCRT 1998
- TTNP 1991
- Country
- TCRT United States
- TTNP United States
- Employees
- TCRT N/A
- TTNP N/A
- Industry
- TCRT Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCRT Health Care
- TTNP Health Care
- Exchange
- TCRT Nasdaq
- TTNP Nasdaq
- Market Cap
- TCRT 3.8M
- TTNP 3.3M
- IPO Year
- TCRT N/A
- TTNP 1996
- Fundamental
- Price
- TCRT $2.04
- TTNP $3.53
- Analyst Decision
- TCRT
- TTNP
- Analyst Count
- TCRT 0
- TTNP 0
- Target Price
- TCRT N/A
- TTNP N/A
- AVG Volume (30 Days)
- TCRT 33.0K
- TTNP 28.0K
- Earning Date
- TCRT 11-14-2024
- TTNP 12-27-2024
- Dividend Yield
- TCRT N/A
- TTNP N/A
- EPS Growth
- TCRT N/A
- TTNP N/A
- EPS
- TCRT N/A
- TTNP N/A
- Revenue
- TCRT $7,000.00
- TTNP $3,000.00
- Revenue This Year
- TCRT N/A
- TTNP N/A
- Revenue Next Year
- TCRT N/A
- TTNP N/A
- P/E Ratio
- TCRT N/A
- TTNP N/A
- Revenue Growth
- TCRT N/A
- TTNP N/A
- 52 Week Low
- TCRT $1.63
- TTNP $3.24
- 52 Week High
- TCRT $33.00
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- TCRT 43.99
- TTNP 40.85
- Support Level
- TCRT $1.63
- TTNP $3.25
- Resistance Level
- TCRT $2.10
- TTNP $3.85
- Average True Range (ATR)
- TCRT 0.30
- TTNP 0.36
- MACD
- TCRT -0.04
- TTNP -0.00
- Stochastic Oscillator
- TCRT 21.03
- TTNP 24.76
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.